Hydrochloric Acid

Hydrochloric Acid

SCHEMBL23905126

CC(C)C[Mg+].[Cl-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22028146 0.95
Bromide SCHEMBL27359012 0.90
Iodide SCHEMBL27117633 0.90
SCHEMBL28999945 0.79
SCHEMBL28765624 0.79
Tetrahydrofuran SCHEMBL28674416 0.74 ALDH1A1 (0.44)
Hydrochloric Acid SCHEMBL28156322 0.68
Bromide SCHEMBL29012710 0.64
Bromide SCHEMBL25362269 0.64
Bromide SCHEMBL21980972 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100548950-C Process for preparing esters and ethers of probucol and derivatives thereof ATHEROGENICS INC (US) 2009-10-14 CN claimed
CN-1759084-A Process for preparing esters and ethers of probucol and derivatives thereof ATHEROGENICS INC (US) 2006-04-12 CN claimed
EP-3892278-B1 CYCLOALKANE-1,3-DIAMINE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2024-02-28 EP disclosed
US-20230074669-A1 CYCLOALKANE-1,3-DIAMINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2023-03-09 US disclosed
US-20230030720-A1 CYCLOALKANE-1,3-DIAMINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2023-02-02 US disclosed
US-11236106-B2 Cycloalkane-1,3-diamine derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-02-01 US disclosed
EP-3892278-A1 CYCLOALKANE-1,3-DIAMINE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2021-10-13 EP disclosed
CN-113164481-A Cycloalkane-1, 3-diamine derivatives 第一三共株式会社 2021-07-23 CN disclosed
CN-101646643-B Method for producing cross-coupled compound KAO CORP 2013-06-05 CN disclosed
CN-101830863-B Method and intermediate compound for preparing ligand of PPAR (Peroxisome Proliferator-Activated Receptor) delta SEOUL NAT UNIV IND FOUNDATION 2011-06-22 CN disclosed
CN-101193876-B Process for preparing ligands for PPAR δ and intermediate compounds useful for preparing the ligands SEOUL NAT UNIV IND FOUNDATION 2011-05-11 CN disclosed
CN-101830863-A The method and the intermediate compound that is used to prepare this part of the part of preparation PPAR δ SEOUL NAT UNIV IND FOUNDATION 2010-09-15 CN disclosed
CN-101646643-A Method for producing cross-coupled compound KAO CORP JP 2010-02-10 CN disclosed
CN-100548950-C Process for preparing esters and ethers of probucol and derivatives thereof ATHEROGENICS INC (US) 2009-10-14 CN disclosed
CN-101391972-A Process of preparing esters and ethers of probucol and derivatives thereof ATHEROGENICS INC (US) 2009-03-25 CN disclosed
CN-101193876-A Process for preparing ligands for PPAR δ and intermediate compounds useful for preparing the ligands JIANG XIANZHONG (KR) 2008-06-04 CN disclosed
CN-1759084-A Process for preparing esters and ethers of probucol and derivatives thereof ATHEROGENICS INC (US) 2006-04-12 CN disclosed